Home » Topics » Conferences

Conferences
RSS

New indication explored for established anticonvulsant

July 21, 1998

EEG analysis reveals the atypical antipsychotic profile of OPC-14597

July 21, 1998

Calcium channel blockers reduce craving for alcohol

July 21, 1998

SIB-1553A goes head-to-head with established cognition-enhancing drugs

July 21, 1998

Hypnotic effects of the benzodiazepine receptor ligand SX-3228 in rats

July 21, 1998

Restless legs syndrome: description and treatment options

July 21, 1998

FR-167653 attenuates ischemia-reperfusion injury to the lung in rat model

July 20, 1998

JTV-519 protects heart during prolonged ischemia

July 20, 1998

Promising immunosuppressive activity reported for KF-20444

July 17, 1998

In vitro and in vivo studies with VX-497 reported at transplant congress

July 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.